Skip to Content
Merck
  • Solving molecular crystal structures from X-ray powder diffraction data: the challenges posed by gamma-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate.

Solving molecular crystal structures from X-ray powder diffraction data: the challenges posed by gamma-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate.

Journal of pharmaceutical sciences (2007-04-25)
Philippe Fernandes, Kenneth Shankland, Alastair J Florence, Norman Shankland, Andrea Johnston
ABSTRACT

The crystal structures of gamma-carbamazepine (P1, Z' = 4) and chlorothiazide N,N-dimethylformamide solvate (1/2) (P2(1)/c, Z' = 2) have been determined from synchrotron and laboratory X-ray powder diffraction data, respectively, using simulated annealing. Both structures represent a significant challenge for global optimization and the successful solutions and subsequent refinements highlight the ever-expanding range of applicability of powder diffraction to structural problems of pharmaceutical relevance.

MATERIALS
Product Number
Brand
Product Description

Supelco
Chlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Chlorothiazide, thiazide diuretic
Chlorothiazide, European Pharmacopoeia (EP) Reference Standard